Tarsus Pharmaceuticals Inc (TARS)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 2.14B
P/E Ratio
0.00
Revenue (TTM)
$ 295.52M
Volume
0
52W High
$ 59.76
52W Low
$ 31.36
Dividend Yield
0.00%
Beta
0.82
Technicals
50-Day MA
48.6576
200-Day MA
48.028
52 Week High
59.76
52 Week Low
31.36
About TARS
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
Employees
323
Headquarters
Irvine, CA
CEO
Dr. Bobak R. Azamian M.D.
Latest News
Tars hand Seawolves first setback | University of Alaska Anchorage - Seawolf Athletics
6 days ago • Google News